Prolonging diabetic remission in cats
With initial insulin and dietary treatments, approximately 30 percent of diabetic cats enter a state of remission in which they no longer require daily insulin shots. Unfortunately, in most cats, remission only lasts a few months and insulin injections are required again for disease control. Exenatide is a medication used to treat people with Type 2 diabetes. The drug stimulates the pancreas to secrete insulin when blood sugar levels are high. It also has the potential to stimulate proliferation of insulin-secreting cells. Researchers will conduct a clinical trial to gauge exenatide’s effectiveness in maintaining and extending diabetic remission in client-owned cats. Current treatment for patients involves daily injections of insulin. Exenatide is given only once a month and holds promise as a more manageable at-home treatment for cats with diabetes.
STUDY ID: D17FE-018
INVESTIGATOR: Chen Gilor, DVM, University of California, Davis